Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer.
暂无分享,去创建一个
Katia Basso | K. Basso | M. Mansukhani | V. Murty | L. Gissmann | S. Nandula | A. Schneider | M. Dürst | Hugo Arias-Pulido | Vundavalli V V S Murty | Matthias Dürst | Gopeshwar Narayan | Subhadra V Nandula | Achim Schneider | Bhavana Pothuri | Mahesh Mansukhani | L. Meyer | B. Pothuri | Lutz Gissmann | Larissa Meyer | Dorcas D Sugirtharaj | Hernan Vargas | Jeannine Villella | G. Narayan | H. Arias-Pulido | J. Villella | H. Vargas
[1] Andrea Califano,et al. SPLASH: structural pattern localization analysis by sequential histograms , 2000, Bioinform..
[2] J. Herman,et al. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. , 2003, Cancer cell.
[3] Peter A. Jones,et al. The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.
[4] E. G. Friedrich,et al. Association of Fanconi's anemia and squamous-cell carcinoma of the lower female genital tract with condyloma acuminatum. A report of two cases. , 1984, The Journal of reproductive medicine.
[5] Andrea Califano,et al. Analysis of Gene Expression Microarrays for Phenotype Classification , 2000, ISMB.
[6] C. Mathew,et al. Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors , 2003, Nature Medicine.
[7] A. D’Andrea,et al. A novel diagnostic screen for defects in the Fanconi anemia pathway. , 2002, Blood.
[8] Hans Joenje,et al. The emerging genetic and molecular basis of Fanconi anaemia , 2001, Nature Reviews Genetics.
[9] Marianne Berwick,et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). , 2003, Blood.
[10] Peter A. Jones,et al. Cancer-epigenetics comes of age , 1999, Nature Genetics.
[11] R. Hruban,et al. Fanconi anemia gene mutations in young-onset pancreatic cancer. , 2003, Cancer research.
[12] G. Evans,et al. Identification of a 6-cM minimal deletion at 11q23.1-23.2 and exclusion of PPP2R1B gene as a deletion target in cervical cancer. , 2000, Cancer research.
[13] M. Mansukhani,et al. Frequent Promoter Methylation of CDH1, DAPK, RARB, and HIC1 Genes in Carcinoma of Cervix Uteri: Its Relationship to Clinical Outcome , 2003, Molecular Cancer.
[14] Bhuvanesh Singh,et al. Comprehensive molecular cytogenetic characterization of cervical cancer cell lines , 2003, Genes, chromosomes & cancer.
[15] R. Chaganti,et al. Allelotype analysis of cervical carcinoma. , 1994, Cancer research.
[16] J. Herman,et al. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. , 2002, Cancer research.
[17] Mei Liu,et al. Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival , 2004, Oncogene.
[18] S. Waggoner. Cervical cancer , 2003, The Lancet.
[19] S. Seal,et al. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition. , 2003, Cancer research.